Sartorius Stedim Biotech S.A. (ENXTPA: DIM)
Health Care · Life Sciences Tools & Services · FR
€214.20
+0.66% today · +11.1% 1Y
Sartorius Stedim Biotech S.A. (ENXTPA: DIM) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $23.18B and employs 10,477 people.
Over the last twelve months the share price has gained 11.1%, trading between 150.00 and 225.00.
Tweenvest scores Sartorius Stedim Biotech S.A. across four factors: quality 68/100, value 42/100, growth 72/100, dividend 15/100. Its strongest factor is growth.
DIM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $23.18B
- Revenue (TTM)
- $3.43B
- P/E
- 70.70
- EPS
- 3.01
- Dividend yield
- 0.33%
- Beta (5Y)
- 1.11
- 52-week high
- €225.00
- 52-week low
- €150.00
- Avg volume (3M)
- —
- Shares outstanding
- 97.30M
- Employees
- 10,477
- Next earnings
- —
About Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A., a global entity and a subsidiary of Sartorius AG, delivers critical instruments, consumables, and services tailored for the biopharmaceutical industry. Their extensive product portfolio includes fundamental components like cell lines, cell culture media, and bioreactors, alongside comprehensive solutions for separation, purification, and concentration processes. They also provide specialized systems for the safe storage and transport of biological intermediates and finished products. For advanced applications, particularly in cell and gene therapy, the company offers both single-use and reusable hollow-fiber membrane devices and presterilized assemblies. Beyond physical products, their service offerings cover vital bioprocessing steps such as cell cultivation, fermentation, filtration, purification, and fluid management, in addition to cell harvesting and broader solutions for intensified bioprocesses. Furthermore, Sartorius Stedim Biotech provides advanced data analytics software designed to model and optimize biopharmaceutical development and production workflows. Serving a diverse customer base, including pharmaceutical, food, and chemical manufacturers, as well as research and development laboratories, the company was founded in 1870 and operates from its headquarters in Aubagne, France.
- ISIN
- FR0013154002
- Founded
- 1978
- Listed since
- Jan 3, 2000
- Exchange
- Euronext Paris
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Mettler-Toledo International Inc.NYSE: MTD | $31.06B | $1,552.89 | +0.19% |
| WuXi Biologics (Cayman) Inc.SEHK: 2269 | $28.16B | HK$53.85 | -0.46% |
| West Pharmaceutical Services, Inc.NYSE: WST | $25.76B | $368.97 | +0.81% |
| Divi's Laboratories LimitedNSEI: DIVISLAB | $25.62B | Rs9,340.00 | +0.98% |
| Sartorius AktiengesellschaftXTRA: SRT3 | $17.70B | €256.10 | +1.23% |
| Revvity, Inc.NYSE: RVTY | $17.20B | $155.05 | +0.56% |
| Medpace Holdings, Inc.NasdaqGS: MEDP | $17.08B | $614.40 | +0.38% |
| Eurofins Scientific SEENXTPA: ERF | $14.99B | €77.98 | +1.12% |
Figures last refreshed Oct 11, 2026.